TegoScience Inc. (KOSDAQ:191420)
12,560
-220 (-1.72%)
At close: Apr 2, 2026
TegoScience Market Cap
TegoScience has a market cap or net worth of 100.56 billion as of April 2, 2026. Its market cap has decreased by -19.74% in one year.
Market Cap
100.56B
Enterprise Value
65.21B
Revenue
5.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,560.00
Market Cap Chart
Since November 6, 2014, TegoScience's market cap has decreased from 110.54B to 100.56B, a decrease of -9.02%. That is a compound annual growth rate of -0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 102.32B | -21.60% |
| Dec 30, 2025 | 130.51B | 30.50% |
| Dec 30, 2024 | 100.00B | -14.80% |
| Dec 28, 2023 | 117.38B | 20.16% |
| Dec 29, 2022 | 97.68B | -43.87% |
| Dec 30, 2021 | 174.03B | -29.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 121.35B |
| BIO-FD&C | 120.70B |
| KoBioLabs | 115.54B |
| ViGenCell | 113.16B |
| CORESTEMCHEMON | 112.23B |
| Quratis | 102.92B |
| CHA Vaccine Research Institute | 100.34B |
| Cell Biotech | 98.55B |